Impact of the Intrapartum Synthetic Oxytocin Dose on Breastfeeding and Endogenous Oxytocin: Cohort study

Not Applicable

• Conditions: ow-risk primipara

• Registration Number: JPRN-UMIN000037783
• Lead Sponsor: St. Luke's International University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-26
• Study Completion: 2021-04-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 95

Inclusion Criteria

Not provided

Exclusion Criteria

1) Cesarean delivery 2) Medical or pregnancy complications (hypertensive disorders of pregnancy, gestational diabetes (more than 2 points), uterine anomalies) 3) History of breast surgery 4) History of mental illness, epilepsy, cancer 5) Taking or inhaling steroids 6) HTLV, HIV, HBV, HCV positive 7) Smoker 8) Alcoholism 9) Illegal drug users 10) Bleeding in mouth (Periodontal disease, bleeding gums, stomatitis) 11) When epidural anesthesia is delivered without using synthetic oxytocin 12) Preterm birth (giving birth before 37 weeks of pregnancy) 13) Birth weight of less than 2500g 14) Oral anomalies in newborns 15) Apgar score of less than 7 at birth in newborns 16) Neonatal admission to NIC

Study & Design

• Study Type: Observational
• Study Design: Not specified